Serum Levels of Anti-Citrullinated Protein Antibody (ACPA) and TWEAK in Patients with Rheumatoid Arthritis: Association with Disease Activity and Treatment Modalities

Creative Commons License

KARKUCAK M., ÇAPKIN E., Cakirbay H., Akyuz A., ALVER A., CANSU A., ...Daha Fazla

TURKISH JOURNAL OF RHEUMATOLOGY, cilt.26, sa.3, ss.204-209, 2011 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 3
  • Basım Tarihi: 2011
  • Doi Numarası: 10.5606/tjr.2011.032
  • Dergi Adı: TURKISH JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.204-209
  • Anahtar Kelimeler: Anti-citrullinated protein antibody, anti-TNF-alpha, rheumatoid arthritis, TWEAK, SA ANTIBODIES, VIMENTIN, CYTOKINE, BLOCKING, PEPTIDE
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Objectives: In this study, we evaluated the serum levels of a serum TNF-related weak inducer of apoptosis (TWEAK) and anti-citrullinated protein antibody (ACPA) and investigated the possible correlation of these parameters with disease activity, cytokine levels and anti-TNF-alpha treatment in patients with rheumatoid arthritis (RA).